Alembic Pharma gets USFDA nod for erectile dysfunction drug

Alembic Pharma gets USFDA nod for erectile dysfunction drug

PTIUpdated: Wednesday, May 29, 2019, 12:38 AM IST
article-image

New Delhi: Drug firm Alembic Pharmaceuticals Wednesday said it has received approval from the US health regulator for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The approval from the United States Food and Drug Administration (USFDA) is for the company’s abbreviated new drug application (ANDA) for Tadalafil tablets USP, in the strengths of 2.5 mg, 5mg, 10mg and 20 mg, Alembic Pharmaceuticals said in a filing to BSE.

The product is generic version of Eli Lilly and Company’s Cialis tablet. Quoting IQVIA data, Alembic Pharma said Tadalafil Tablets have an estimated market size of USD 1.8 billion for twelve months ending December 2018. The company currently has a total of 89 ANDA approvals (77 final approvals and 12 tentative approvals) from USFDA, it added. Shares of Alembic Pharmaceuticals were trading 0.23 per cent lower at Rs 528.35 apiece on BSE.

RECENT STORIES

Attention Debit Card Holders, Your Maintenance Charges Are Set To Spike: THIS Bank Has Revised The...

Attention Debit Card Holders, Your Maintenance Charges Are Set To Spike: THIS Bank Has Revised The...

Rock Solid: Citroen Basalt Vision Revealed

Rock Solid: Citroen Basalt Vision Revealed

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Century Textile Shares Rocket Bullishly; Surge Over 10%

Century Textile Shares Rocket Bullishly; Surge Over 10%

Adani's Copper Unit In Mundra Begins Operations

Adani's Copper Unit In Mundra Begins Operations